|1.||Shao, Lingyun: 5 articles (11/2015 - 01/2012)|
|2.||Zhang, Wenhong: 5 articles (11/2015 - 01/2012)|
|3.||Wu, Jing: 4 articles (11/2015 - 01/2012)|
|4.||Weng, Xinhua: 4 articles (11/2015 - 01/2012)|
|5.||Diao, Ni: 4 articles (01/2015 - 01/2012)|
|6.||Prasad, Puttur D: 4 articles (09/2008 - 06/2005)|
|7.||Ganapathy, Vadivel: 4 articles (09/2008 - 06/2005)|
|8.||Wang, Sen: 3 articles (11/2015 - 01/2012)|
|9.||Gao, Yan: 3 articles (11/2015 - 01/2012)|
|10.||Zhang, Shu: 3 articles (11/2015 - 01/2012)|
|1.||Lung Neoplasms (Lung Cancer)
12/01/2009 - "We show for the first time that these drugs also were highly effective for treatment of experimental lung cancer, and all triterpenoid and rexinoid combinations reduced ATB 85% to 87% compared with the control group. "
07/01/2009 - "Previous studies have shown significant chemopreventive efficacy of ATB against human esophageal and lung cancers. "
05/06/2004 - "Previously, clinical studies have shown a significant chemopreventive efficacy of ATB against human esophageal and lung cancers. "
05/06/2004 - "Mice with various genotypes treated with ATB displayed a significant reduction in lung tumor multiplicity and tumor load. "
03/01/2015 - "ATB(0,+), as well as LAT1, could contribute significantly to the tumor accumulation of BPA at clinical dose."
08/01/2014 - "In conclusion, the non-natural cationic amino acid PET probe [(18)F]FEMAET accumulates in cancer cells in vitro and in vivo with possible involvement of ATB(0,+)."
05/01/2013 - "ATB treatment of wild-type mice reduced the incidence and severity of tumors. "
12/01/2008 - "Tumor cells harvested during surgery underwent methylthiazolyl tetrazolium blue (MTT) cytotoxic assay. "
11/01/2013 - "With ongoing complications due to emerging ATB resistance, novel treatment strategies are necessary to control ExPEC infections. "
12/01/2015 - "Our data therefore reveal a profound effect of Ss infection on the systemic cytokine responses in ATB and LTB and indicate that coincident helminth infections might influence pathogenesis of TB infection and disease. "
11/01/2015 - "To investigate the distributions and functions of T cell subsets (i.e., CD3+, CD4+, CD8+ αβ and Vγ2Vδ2+ T cells) in HIV-negative subjects with different M.tb infection statuses, we conducted a case-control study that enrolled 125 participants, including ATB patients (n=46), LTBI subjects (n=34), and HC (n=45). "
02/18/2015 - "Fifty-eight children with aTB and 76 with latent TB infection (LTBI) were included and they were compared to 90 non-infected children. "
01/01/2015 - "Prevalence of ATB prescription errors in this emergency department was generally high and was particularly common with cephalosporin, narrow-spectrum ATBs, and UTI infections."
01/01/1990 - "In patients with ATB prophylaxis the prevalence of bacteremia after the treatment amounted to 17%."
01/01/1990 - "Immediately after the treatment the prevalence of bacteremia amounted to 80% in a group of ATB-free patients. "
09/01/2014 - "In "PI plus ATB versus ATB" trials, the risk of fever (RR 0.11; 95 % CI 0.02-0.85, P = 0.03) and bacteremia (RR 0.25; 95 % CI 0.08-0.75, P = 0.01) was diminished in the "PI plus ATB" group. "
09/01/2014 - "With PI versus antibiotics (ATB), patients treated with ATB alone had a significantly greater risk of bacteremia (RR 0.38; 95 % CI 0.16-0.90, P = 0.03). "
08/01/2011 - "Though intestinal glutamine transport was reported to be impaired in late sepsis, we hypothesized that there might be a different alteration in the early stage, with differential effects on the Na(+)-dependent glutamine transporters B(0)AT1, ATB(0,+), and ATA2. "
11/01/2013 - "This shift from the traditional Gram-positive bacterial causes of nosocomial and neonatal sepsis infections could be attributed to the use of intrapartum chemoprophylaxis against Gram-positive bacteria and the appearance of antibiotic (ATB) resistance in E. "
11/01/2007 - "Risk factors such as underlying disease (diabetes mellitus, cancer, trauma, neonatal age, splenectomy, alcoholism, sepsis, other infections), etiology, clinical symptoms and outcome (death, improvement and cured after modifications of ATB therapy, cured without change of therapy, cured with neurologic sequellae) were recorded and analysed with univariate analysis (chi2 or t test for trends, CDC Atlanta 2004). "
|1.||Anti-Bacterial Agents (Antibiotics)
|3.||Untranslated RNA (Noncoding RNA)
|5.||Interferon-gamma (Interferon, gamma)
|6.||Transforming Growth Factors (Transforming Growth Factor)
|7.||2- cyano- 3,12- dioxooleana- 1,9(11)- dien- 28- oic acid ethyl amide
|2.||Drug Therapy (Chemotherapy)